Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1182 |
| Name of the vaccine | V710 |
| Microbe | Bacteria |
| Disease name | Methicillin-Resistant Staphylococcus aureus (MRSA) |
| Name of bacteria | Staphylococcus aureus |
| Type of vaccine | Recombinant |
| Nucleic acid content | Circular DNA |
| Age | 18 years and older |
| Description of the vaccine | Containing S. aureus 0657nI iron surface determinate B (IsdB). |
| Name of the manufacturer | Merck Sharp & Dohme Corp |
| Name of the manufacturing country | Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Germany, Guatemala, Ireland, Italy, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Peru, Russian Federation, Singapore, Spain, Sweden, Taiwan, United Kingdom, United States |
| Year of manufacture | 2011 |
| Clinical Phase status | Clinical - Failed |
| Bacterial strain | Gram-positive bacteria. |
| Efficacy | 18.50% |
| Vaccine formulation | NA |
| Dosage | Single dose of 0.5 mL. |
| Mechanism of action | IgG-antibody responses against IsdB. |
| Route of administration | Intramuscular |
| Indications | Prevents serious Staphylococcus aureus infections following elective cardiothoracic surgery. |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For Bacteremia and mediastinitis. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | 25483690 |
| Clinical trial number | NCT00518687 |
| Reference | https://www.fda.gov/media/109113/download |
| Other name | NA |
| Additional Links | NA |